MAGNACHIP SEMICONDUCTOR CORP (MX)

US55933J2033 - Common Stock

5.065  +0.14 (+2.74%)

Fundamental Rating

2

Taking everything into account, MX scores 2 out of 10 in our fundamental rating. MX was compared to 107 industry peers in the Semiconductors & Semiconductor Equipment industry. The financial health of MX is average, but there are quite some concerns on its profitability. MX does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

MX had negative earnings in the past year.
MX had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: MX reported negative net income in multiple years.
Of the past 5 years MX 4 years had a positive operating cash flow.

1.2 Ratios

The Return On Assets of MX (-8.71%) is worse than 68.87% of its industry peers.
The Return On Equity of MX (-10.63%) is worse than 66.98% of its industry peers.
Industry RankSector Rank
ROA -8.71%
ROE -10.63%
ROIC N/A
ROA(3y)-0.18%
ROA(5y)11.23%
ROE(3y)0.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 22.44%, MX is not doing good in the industry: 78.30% of the companies in the same industry are doing better.
MX's Gross Margin has declined in the last couple of years.
MX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.91%
GM growth 5Y-2%

5

2. Health

2.1 Basic Checks

MX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MX has been reduced compared to 1 year ago.
Compared to 5 years ago, MX has more shares outstanding
The debt/assets ratio for MX is higher compared to a year ago.

2.2 Solvency

MX has an Altman-Z score of 3.15. This indicates that MX is financially healthy and has little risk of bankruptcy at the moment.
MX's Altman-Z score of 3.15 is in line compared to the rest of the industry. MX outperforms 50.00% of its industry peers.
MX has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.00, MX is doing good in the industry, outperforming 71.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.15
ROIC/WACCN/A
WACC10.28%

2.3 Liquidity

MX has a Current Ratio of 5.23. This indicates that MX is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 5.23, MX is doing good in the industry, outperforming 79.25% of the companies in the same industry.
MX has a Quick Ratio of 4.54. This indicates that MX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of MX (4.54) is better than 78.30% of its industry peers.
Industry RankSector Rank
Current Ratio 5.23
Quick Ratio 4.54

2

3. Growth

3.1 Past

The earnings per share for MX have decreased strongly by -325.88% in the last year.
Looking at the last year, MX shows a very negative growth in Revenue. The Revenue has decreased by -31.89% in the last year.
MX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -13.14% yearly.
EPS 1Y (TTM)-325.88%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q87.78%
Revenue 1Y (TTM)-31.89%
Revenue growth 3Y-23.16%
Revenue growth 5Y-13.14%
Revenue growth Q2Q-16.69%

3.2 Future

The Earnings Per Share is expected to decrease by -54.22% on average over the next years. This is quite bad
Based on estimates for the next years, MX will show a quite strong growth in Revenue. The Revenue will grow by 9.56% on average per year.
EPS Next Y-220.09%
EPS Next 2Y-54.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.07%
Revenue Next 2Y9.56%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MX. In the last year negative earnings were reported.
Also next year MX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as MX's earnings are expected to decrease with -54.22% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-54.22%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MX!.
Industry RankSector Rank
Dividend Yield N/A

MAGNACHIP SEMICONDUCTOR CORP

NYSE:MX (5/3/2024, 10:25:32 AM)

5.065

+0.14 (+2.74%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap193.79M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.71%
ROE -10.63%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 22.44%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 5.23
Quick Ratio 4.54
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-325.88%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-220.09%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-31.89%
Revenue growth 3Y-23.16%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y